Danatlas Pharmaceuticals
- Biotech or pharma, therapeutic R&D
Danatlas is a clinical-stage biopharmaceutical leader developing novel therapies targeting synthetic lethal mechanisms in DNA damage repair pathways. Headquartered in Beijing with a U.S. subsidiary in Boston, we pioneer precision medicines addressing unmet needs in breast, gynecological, gastrointestinal, and genitourinary cancers through transformative.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}